Skip to main content
Axi-cel a promising second-line treatment option for older patients with relapsed or refractory LBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Axi-cel a promising second-line treatment option for older patients with relapsed or refractory LBCL
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Refractory
0
0.82
Stem Cell Research and Therapy
0
0.78
B-Cell Lymphoma
0
1
Lymphoma
0
0.33
Cell Transplantation
0
0.23
Cancer
0
0.16
Chemotherapy
0
0.16
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.83
Edit Tags